Statistics for Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease
Total visits
views | |
---|---|
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease | 118 |
Total visits per month
views | |
---|---|
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 5 |
April 2025 | 10 |
May 2025 | 3 |
File Visits
views | |
---|---|
Sands2021Efficacy-AAM.pdf | 393 |
java.util.UUID:245190c9-29f6-4945-8a93-5f0afa3cba12 | 185 |
java.util.UUID:75bd9093-29be-42d5-b441-2441215d2798 | 15 |
java.util.UUID:9a17a614-b214-4868-a32d-b53fd8cac5bd | 5 |
Top country views
views | |
---|---|
United States | 76 |
Germany | 16 |
China | 3 |
Spain | 3 |
Iran | 2 |
Poland | 2 |
Austria | 1 |
Czechia | 1 |
United Kingdom | 1 |
Italy | 1 |
South Korea | 1 |
Malaysia | 1 |
Philippines | 1 |
Sweden | 1 |
Top city views
views | |
---|---|
Wilmington | 45 |
Kiez | 10 |
Gunzenhausen | 6 |
Cambridge | 3 |
Chicago | 3 |
Fairfield | 3 |
Ejea de los Caballeros | 2 |
Los Angeles | 2 |
Mount Laurel | 2 |
Warsaw | 2 |
White Plains | 2 |
Ashburn | 1 |
Beijing | 1 |
Dongjak-gu | 1 |
Houston | 1 |
Indianapolis | 1 |
Laurel | 1 |
Manila | 1 |
Niantic | 1 |
Prague | 1 |
Rochester | 1 |
San Jose | 1 |
Seremban | 1 |
Seville | 1 |
Stockholm | 1 |
Taishing | 1 |
Tehran | 1 |
Verona | 1 |